| |
| |
|
| Insider
Information: |
Malik Fady Ibraham |
| Relationship: |
EVP Research & Develop... |
| City: |
South San Francisco |
| State: |
CA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
1 |
|
| Direct
Shares |
120,920 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$6,364,020 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
120,920 |
|
|
| Total
Value |
$6,364,020 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
13
|
|
Stock
price went up :
|
0
|
5
|
| Stock
price went down : |
0
|
8
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
 -426.3%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Cytokinetics Inc |
CYTK |
EVP Research & Develop... |
2024-09-17 |
120,920 |
|
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
132 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 5 of 6
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| CYTK |
Cytokinetics Inc |
EVP Research & Development |
• • – |
2023-06-08 |
4 |
AS |
$38.07 |
$95,175 |
D/D |
(2,500) |
163,164 |
0 |
% |
|
| CYTK |
Cytokinetics Inc |
EVP Research & Development |
• • – |
2023-02-09 |
4 |
OE |
$7.96 |
$55,720 |
D/D |
7,000 |
163,589 |
0 |
- |
|
| CYTK |
Cytokinetics Inc |
EVP Research & Development |
• • – |
2022-11-10 |
4 |
AS |
$38.04 |
$152,160 |
D/D |
(4,000) |
164,346 |
0 |
% |
|
| CYTK |
Cytokinetics Inc |
EVP Research & Development |
• – – |
2021-03-11 |
4 |
AS |
$19.90 |
$39,798 |
D/D |
(2,000) |
164,348 |
0 |
- |
|
| CYTK |
Cytokinetics Inc |
EVP Research & Development |
• • – |
2023-05-11 |
4 |
AS |
$39.50 |
$70,587 |
D/D |
(1,787) |
165,396 |
0 |
% |
|
| CYTK |
Cytokinetics Inc |
EVP Research & Development |
• – – |
2021-03-08 |
4 |
D |
$19.19 |
$146,496 |
D/D |
(7,634) |
166,348 |
0 |
- |
|
| CYTK |
Cytokinetics Inc |
EVP Research & Development |
• • – |
2023-04-13 |
4 |
AS |
$34.21 |
$136,840 |
D/D |
(4,000) |
167,183 |
0 |
% |
|
| CYTK |
Cytokinetics Inc |
EVP Research & Development |
• • – |
2023-05-03 |
4 |
AS |
$40.00 |
$280,000 |
D/D |
(7,000) |
167,183 |
0 |
% |
|
| CYTK |
Cytokinetics Inc |
EVP Research & Development |
• • – |
2024-03-05 |
4 |
OE |
$6.67 |
$190,789 |
D/D |
28,604 |
167,577 |
0 |
- |
|
| CYTK |
Cytokinetics Inc |
EVP Research & Development |
• – – |
2022-03-07 |
4 |
D |
$36.83 |
$365,206 |
D/D |
(9,916) |
168,084 |
0 |
- |
|
| CYTK |
Cytokinetics Inc |
EVP Research & Development |
• – – |
2022-03-10 |
4 |
AS |
$37.82 |
$1,015,462 |
D/D |
(26,852) |
168,084 |
0 |
- |
|
| CYTK |
Cytokinetics Inc |
EVP Research & Development |
• – – |
2022-04-07 |
4 |
AS |
$42.58 |
$985,755 |
D/D |
(23,148) |
168,084 |
0 |
- |
|
| CYTK |
Cytokinetics Inc |
EVP Research & Development |
• – – |
2022-05-12 |
4 |
AS |
$37.54 |
$525,075 |
D/D |
(13,987) |
168,084 |
0 |
- |
|
| CYTK |
Cytokinetics Inc |
EVP Research & Development |
• • – |
2022-06-09 |
4 |
AS |
$40.62 |
$873,330 |
D/D |
(21,500) |
168,346 |
0 |
- |
|
| CYTK |
Cytokinetics Inc |
EVP Research & Development |
• • – |
2022-07-14 |
4 |
AS |
$43.43 |
$933,745 |
D/D |
(21,500) |
168,346 |
0 |
% |
|
| CYTK |
Cytokinetics Inc |
EVP Research & Development |
• • – |
2022-09-08 |
4 |
AS |
$51.88 |
$1,115,420 |
D/D |
(21,500) |
168,346 |
0 |
% |
|
| CYTK |
Cytokinetics Inc |
EVP Research & Development |
• • – |
2022-10-13 |
4 |
AS |
$47.28 |
$1,017,135 |
D/D |
(21,513) |
168,346 |
0 |
% |
|
| CYTK |
Cytokinetics Inc |
EVP Research & Development |
• • – |
2024-04-09 |
4 |
OE |
$6.67 |
$190,795 |
D/D |
28,605 |
171,172 |
0 |
- |
|
| CYTK |
Cytokinetics Inc |
EVP Research & Development |
• • – |
2023-03-09 |
4 |
AS |
$39.10 |
$156,400 |
D/D |
(4,000) |
171,183 |
0 |
% |
|
| CYTK |
Cytokinetics Inc |
EVP Research & Development |
• – – |
2021-12-09 |
4 |
OE |
$6.30 |
$183,746 |
D/D |
29,166 |
172,053 |
0 |
- |
|
| CYTK |
Cytokinetics Inc |
EVP Research & Development |
• – – |
2021-03-02 |
4 |
A |
$0.00 |
$0 |
D/D |
35,000 |
173,982 |
0 |
- |
|
| CYTK |
Cytokinetics Inc |
EVP Research & Development |
• • – |
2023-05-03 |
4 |
OE |
$7.96 |
$55,720 |
D/D |
7,000 |
174,183 |
0 |
- |
|
| CYTK |
Cytokinetics Inc |
EVP Research & Development |
• • – |
2023-03-06 |
4 |
A |
$0.00 |
$0 |
D/D |
40,000 |
175,183 |
0 |
- |
|
| CYTK |
Cytokinetics Inc |
EVP Research & Development |
• • – |
2024-02-06 |
4 |
OE |
$6.67 |
$190,795 |
D/D |
28,605 |
175,578 |
0 |
- |
|
| CYTK |
Cytokinetics Inc |
EVP Research & Development |
• – – |
2022-03-02 |
4 |
A |
$0.00 |
$0 |
D/D |
30,000 |
178,000 |
0 |
- |
|
132 Records found
|
|
Page 5 of 6 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
